Stifel Financial Corp Cue Biopharma, Inc. Transaction History
Stifel Financial Corp
- $85.8 Billion
- Q1 2024
A detailed history of Stifel Financial Corp transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 192,592 shares of CUE stock, worth $188,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
192,592
Previous 193,975
0.71%
Holding current value
$188,740
Previous $512,000
29.1%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CUE
# of Institutions
78Shares Held
16.3MCall Options Held
12.9KPut Options Held
39.1K-
Bleichroeder LP New York, NY2.76MShares$2.7 Million1.61% of portfolio
-
Slate Path Capital LP New York, NY2.4MShares$2.35 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$2.24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.24MShares$2.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA839KShares$821,7600.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $34.7M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...